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Abstract Introduction: Later-life brain alterations in former tackle football players are poorly understood,
particularly regarding their relationship with repetitive head impacts (RHIs) and clinical function.
We examined white matter signal abnormalities (WMSAs) and their association with RHIs and clin-
ical function in former National Football League (NFL) players.
Methods: Eighty-six clinically symptomatic former NFL players and 23 same-age reportedly
asymptomatic controls without head trauma exposure underwent magnetic resonance imaging and
neuropsychological testing. FreeSurfer calculated WMSAs. A cumulative head impact index quan-
tified RHIs.
Results: In former NFL players, increased volume of WMSAs was associated with higher cumula-
tive head impact index scores (P 5 .043) and worse psychomotor speed and executive function
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(P5 .015). Although former NFL players had greater WMSAvolume than controls (P5 .046), these
findings are inconclusive due to recruitment of controls based on lack of clinical symptoms and head
trauma exposure.
Discussion: In former NFL players, WMSAsmay reflect long-termmicrovascular and nonmicrovas-
cular pathologies from RHIs that negatively impact cognition.
 2017 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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1. Introduction
Chronic traumatic encephalopathy (CTE) is a neurode-
generative disease associated with recurrent concussive
and subconcussive injuries (i.e., repetitive head impacts
[RHIs]) [1,2] and is commonly observed in former boxers
and professional American football players [1–4]. CTE
can currently only be diagnosed through neuropathological
examination [5], in part, because biomarkers that can accu-
rately detect CTE in vivo do not yet exist. Research has
begun to use neuroimaging to study the long-term effects
of RHIs on the brain and to identify methods to detect neuro-
logical sequelae from RHIs (including CTE), focusing on
former professional football players due to their substantial
exposure to RHIs. Structural [6,7], functional [7,8], and
neurochemical [6,9] brain changes have been found in this
cohort, believed to be a result of RHIs, and may affect
cognitive and neuropsychiatric function [10,11]. Later-life
brain alterations in former football players are not fully char-
acterized, particularly in terms of their relationship with
RHIs and clinical function. Former NFL players are presum-
ably at high risk for CTE [4] and can serve as a population to
provide insight into the potential in vivo structural brain
changes associated with CTE (e.g., Hart et al. [7], Koerte
et al. [12]).
White matter signal abnormalities (WMSAs) may be
common magnetic resonance imaging (MRI) findings that
correlate with clinical function in former football players.
WMSAs refer to regions in the white matter that appear
hyperintense on T2 fluid-attenuated inversion recovery
(FLAIR) but hypointense on T1-weighted images, such as
magnetization-prepared rapid gradient echo (MPRAGE)
scans. The etiology underlying WMSAs is nonspecific and
may be multifaceted. WMSAs have been documented to
accompany aging and cardiovascular disease (CVD) and
usually are interpreted to reflect small-vessel cerebrovascu-
lar disease from microvascular hypoperfusion [13–17].
Reduced cerebral perfusion has been observed in active
and former National Football League (NFL) players [7,8],
and previous research reports greater total and deep volume
WMSAs in 10 former NFL players with cognitive deficits,
comparedwith age-matched controls [7]. Subcortical or peri-
ventricular WMSAs were also observed in 7/9 former NFL
players from a clinical case series [18]. Former professional
football playersmay be at risk for the pathologies ofWMSAs
due to their high rates of CVD [19,20]. WMSAs may also
reflect long-term microvascular and nonmicrovascular pa-
thologies from RHIs. In the setting of acute mild traumatic
brain injury (mTBI), WMSAs can be common, perhaps
from decreases in cerebral perfusion [21–23], and they
predict post-mTBI cognitive outcomes [21,24]. RHIs are
also associated with impaired cerebral hemodynamics in
active boxers [25], andWMSAs in active collegiate ice hock-
ey players have been shown to occur closer to the gray and
white matter interface compared with controls [26]. This sul-
cal depth location ofWMSAs was suggestive of head trauma
as the precipitant cause, particularly given that the diagnostic
lesion of CTE is the perivascular deposition of hyperphos-
phorylated tau (p-tau) at the base of the sulci [5]. There
may indeed be a vascular component, including blood-
brain barrier leakage, involved in the RHI and neurofibrillary
tangle formation relationship [27–30]. In autopsy cases of
“dementia pugilistica,” decreased microvascular density
and fragmented vessels in the frontal cortex were observed,
and tau and microvascular pathology correlated [29]. Along
with microvascular changes, RHIs and CTE are also associ-
atedwith neurometabolic disturbances (e.g., gliosis, neuroin-
flammation) [2,9,31,32], especially diffuse axonal injury
[2,7,33,34], that could result in WMSAs [35–37].
WMSAs have long been studied in Alzheimer’s disease
(AD). WMSAs predict increased risk for AD dementia
[38]. In fact, WMSAs have even been postulated to be a
core feature of AD, given WMSAs were increased in
autosomal-dominant AD patients before symptom onset
and predicted cerebrospinal fluid amyloid b levels in carriers
only [39]. Although the clinical presentation of CTE is het-
erogeneous and includes a constellation of various cognitive
(including nonmemory impairments), behavior, and mood
symptoms [3,4,40], the pathologies of WMSAs may
contribute to the clinical presentation of CTE as they do in
AD.
This study examined the association between RHIs (using
the cumulative head impact index [CHII]; [10]) and volume
of WMSAs from T1-weighted MPRAGE MRI in symptom-
atic former NFL players. The association between WMSAs
and cognitive and neuropsychiatric function was also inves-
tigated. It was hypothesized that increased volume of
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WMSAs would be associated with greater exposure to RHIs
and worse clinical function.
2. Methods
2.1. Study design(s)
The current sample included 86 former NFL players from
the National Institutes of Health–funded “Diagnosing and
Evaluating Traumatic Encephalopathy using Clinical Tests”
(DETECT) study. The purpose of DETECT is to identify
in vivo biomarkers for CTE. Eligibility criteria for the former
NFL players included the following: male, age of 40–69
years, a minimum of two NFL seasons and 12 years of
organized tackle football, and self-reported cognitive,
behavioral, and/or mood symptoms. Also recruited was a
same-age comparison group (n 5 23), who had no history
of contact sport participation, service in the military, or
self-reported TBI, and denied symptoms (at telephone
screen); because of inherent recruitment bias, they served
as “controls” for secondary analyses. Exclusion criteria for
the DETECT study included MRI or lumbar puncture con-
traindications, presence of another central nervous system
disease, and/or primary language other than English. The
sample size was reduced from 96 former NFL players and
25 same age controls following exclusion of participants
who either did not complete MRI or whose structural MRI
data acquisition was of inadequate quality. Participants
completed a 2- to 3-day visit involving demographic, medi-
cal, and athletic history interview(s), neurological evalua-
tion, neuropsychological testing, structured psychiatric
interview, self-report behavior/mood measures, and MRI.
Study protocols were approved by the local Institutional
Review Boards, and participants provided written informed
consent.
2.2. Measures
2.2.1. MRI
All participants underwent MRI on a 3T Siemens Verio
MRI scanner with a 32-channel head coil. Three-
dimensional T1-weighted sequences (MPRAGE [1! 1!
1 mm3, TR 5 1800 ms, TE 5 3.36 ms]) were acquired.
The T1-weighted images were visually inspected for arti-
facts and intrascan misalignments, and those with significant
artifacts were excluded. Postprocessing of all images was
conducted by the Psychiatry Neuroimaging Laboratory,
Brigham andWomen’s Hospital. Brain masks were automat-
ically generated based on T2-weighted images and were
manually corrected. T2-weighted data optimized contrasts
between the brain and the surrounding exterior cerebrospinal
fluid (CSF). The T1-weighted images and the brain masks
were imported into FreeSurfer 5.3 software. The FreeSurfer
automated segmentation process of brain tissue has been
described elsewhere [41,42], but it subdivides the brain
into regions of gray matter, white matter, and hypointense
regions within the white matter using a combination of
segmentation and a set of priors. Total volume of white
matter hypointensities is an averaged composite of the left
and right hemispheres. Visual quality assessment was
performed following the FreeSurfer segmentation to
ensure FreeSurfer included the entire brain and for overall
completeness of the FreeSurfer segmentation. Quality
control also included checking for proper detection of
white and gray matter borders. If FreeSurfer did not detect
white and gray matter borders correctly (leading to
distorted segmentations), fiducials were set in neighboring
white matter regions allowing the software to correctly
define the tissue. Total volume of WMSAs (i.e., white
matter hypointensities) and supratentorial volume (SV)
were extracted from FreeSurfer output. SV served as a
covariate in analyses.
2.2.2. Cumulative head impact index
The CHII was developed in a sample of former amateur
American football players to estimate cumulative head
impact exposure from football [10]. The CHII is based on
self-reported number of seasons of football played and posi-
tion(s) at each level played, and estimated head impact expo-
sure frequencies from published helmet accelerometer
studies in former amateur football players. Published helmet
accelerometer studies at the professional level do not exist.
For the present sample of former NFL players, college-
level estimates of head impact frequencies were applied
for their professional football exposure, in addition to the
self-reported seasons and positions played in the NFL. Pre-
vious work in former NFL players from the DETECT study
has linked CHII scores with higher total concentrations of
plasma total tau [43]. Higher CHII reflects greater exposure
to RHIs.
2.2.3. Neuropsychological and neuropsychiatric measures
Participants were administered a neuropsychological bat-
tery to evaluate attention, executive function, verbal and vi-
sual episodic memory, language, and visuospatial function.
Participants completed semi-structured interviews and self-
report measures of neuropsychiatric function (e.g., depres-
sion, aggression). The tests administered have been previ-
ously reported [44]. Neuropsychological test raw scores
were transformed to standard scores that account for age,
gender, and/or education. As described elsewhere [44], prin-
cipal component analysis generated four composite factors
measuring the following domains: behavioral/mood, psy-
chomotor speed/executive function, and verbal and visual
memory.
2.2.4. Modified Framingham Stroke Risk Profile
The Framingham Stroke Risk Profile (FSRP) is a widely
used metric of CVD [45] and was included to account for
CVD as a possible etiology of the WMSAs. The FSRP is
calculated using an algorithm based on age, systolic blood
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pressure, hypertensive medication, diabetes, cigarette smok-
ing, prior CVD, atrial fibrillation, and left ventricular hyper-
trophy. History of atrial fibrillation was deduced from
medication status, whereas history of diabetes, cigarette
smoking, and prior CVD (myocardial infarction, heart dis-
ease) were self-reported. Thirty-eight former NFL players
were 54 years and were assigned a score of 0 for age.
The FSRP raw risk score was calculated without left ventric-
ular hypertrophy because this was not part of data collection.
This has been done previously [46].
2.3. Statistical analyses
For analyses that examined WMSAs as the outcome, the
WMSA variable was log-transformed due to a positively
skewed distribution. In the 86 former NFL players, multivar-
iable linear regression tested the association between the
CHII and log-WMSAs. Linear regressions were used to
examine the correlations between volume of WMSAs and
the clinical domains (behavior/mood, psychomotor speed/
executive function, and verbal and visual episodic memory).
A separate model was performed for each domain. For ana-
lyses examining clinical function, the sample size was
reduced to 76 due to missing data on tests that make up
the domain factor scores (only participants with complete
data on all of the factor scores were included in the ana-
lyses), and two were excluded due to objective test evidence
of intentional symptom exaggeration. All analyses
controlled for age, SV, and the mFSRP. Analyses were also
repeated with race as a covariate, given 41.9% of the former
NFL players were African American. Body mass index
(BMI) was not included as a covariate, given the confound
of BMI would largely stem from its association with CVD
(as accounted for by the mFSRP). BMI is highly associated
with the CHII (r5 0.34, P5 .002) and is perhaps serving as
a proxy for RHI exposure, as it reflects the person’s playing
position, that is, offensive linemen tend to have the highest
level of RHI exposure [47] and the highest BMI [48]. In
this sample, linemen had a higher BMI, compared with non-
linemen (mean difference 5 2.78, P 5 .009).
For the secondary analyses, analysis of covariance
compared log-WMSAs between the 86 symptomatic former
NFL players and 23 same-age asymptomatic controls. Cova-
riates included age and SV. The groups had nearly identical
mFSRP scores (Table 1); therefore, the mFSRP was not
included as a covariate. Race and BMI were not included
as covariates in the between-group comparison. There is
not a large enough sample of African American controls
(n 5 1) to accurately estimate the differential effects of
race on WMSAs between the former NFL players and con-
trols. The mFSRP and SV are examined and accounted for
and thus attenuate concerns for confound from race. BMI
Table 1
Sample characteristics of 86 former NFL players and 23 controls
Demographic/athletic/health variables NFL (n 5 86) Control (n 5 23) P value*
Demographics
Age, mean (SD) years 54.86 (7.91) 57.22 (6.89) .20
Education, mean (SD) years 16.43 (0.97) 17.30 (2.14) .07
African American, n (%) 36 (41.9) 1 (4.3) ,.001
Athletics
Duration of football play, mean (SD) years 18.41 (3.44) – –
Cumulative head impact index, mean (SD) 20,489.97 (7178.64) – –
Primary position group, n (%)
Offensive line 25 (29.1) – –
Running back 8 (9.3) – –
Tight end 4 (4.7) – –
Offensive skill 1 (1.2) – –
Defensive line 13 (15.1) – –
Linebacker 20 (23.3) – –
Defensive back 15 (17.4) – –
Cardiovascular disease status
Body mass index, mean (SD) 32.96 (4.99) 28.02 (3.90) ,.001
Systolic blood pressure, mean (SD) 129.70 (15.78) 135.09 (12.94) .14
Treated for hypertension, n (% yes) 57 (66.3) 17 (73.9) .49
History of diabetes, n (% yes) 7 (8.1) 1 (4.3) 1.00
History of cigarette smoking, n (% yes) 3 (3.5) 0 1.00
History of cardiovascular disease, n (% yes) 10 (11.6) 0 .12
History of atrial fibrillation, n (% yes) 4 (4.7) 0 .58
yModified Framingham Stroke Risk Profile, mean (SD) 6.42 (3.34) 6.39 (2.50) .97
Abbreviations: NFL, National Football League; SD, standard deviation.
NOTE. Eligibility criteria for the control group required lack of reported symptoms and no history of head trauma or participation in contact sports.
*Independent sample t tests were performed for continuous outcomes, and Fisher’s exact test was used to compare group differences in race, history of dia-
betes, history of cigarette smoking, history of cardiovascular disease, and history of atrial fibrillation; c2 test was used to examine differences on those treated for
hypertension.
yThe Framingham Stroke Risk Profile is a modified version and did not include left ventricular hypertrophy.
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was not included as a covariate, given the groups were
similar in vascular status.
3. Results
In the former NFL players, a higher CHII score was associ-
ated with increased volume ofWMSAs (P5 .043; Fig. 1), and
increased volume of WMSAs predicted worse psychomotor
speed/executive function (P 5 .015). See Table 2 for clinical
test performance and Table 3 for a summary of the linear
regression analyses. There were no significant effects for the
other cognitive domains (P. .10). In the former NFL players,
analysis of covariance controlling for age and SV showed that
African Americans had greater volume of WMSAs (marginal
mean difference 5 20.17, 95% confidence interval
[CI]520.28,20.05,P5.008) andworse psychomotor speed
and executive function (only controlling for age; marginal
mean difference 5 20.78, 95% CI 5 21.13, 20.44,
P, .001), compared to Caucasians. When race was added as
a covariate to the analyses in the formerNFL players, the effect
of the CHII on WMSAs remained statistically significant
(P5 .021) and the association between WMSAs and psycho-
motor speed and executive function was diminished to a statis-
tical trend (P 5 .061). Additional secondary analyses showed
that the former NFL players had greater volume of WMSAs
compared with the asymptomatic controls without a history
of head trauma (marginal mean difference 5 20.11, 95%
CI5 20.22,20.002, F5 4.07, P5 .046).
4. Discussion
In this study, greater exposure to RHIs predicted
increased volume of WMSAs in the former NFL players, af-
ter controlling for age, CVD, and SV (and race). In the
former NFL players, increased volume of WMSAs corre-
sponded to worse performance on tests of psychomotor
speed and executive function, but not with measures of
episodic memory or neuropsychiatric function. These find-
ings provide evidence that exposure to RHIs may result in
long-term pathological changes that manifest, at least in
part, as WMSAs on MRI and are associated with cognition.
Secondary analyses further showed that the symptomatic
former NFL players exhibited greater volume of WMSAs
compared with asymptomatic male controls without a his-
tory of head trauma or contact sport participation. It is
important to note that the former NFL players were required
to be symptomatic (at telephone screen), whereas the con-
trols must have been asymptomatic (at telephone screen)
and have no history of head trauma. Therefore, the higher
levels of WMSAs observed in the former NFL players
compared with controls may not only be a result of exposure
to RHIs but may also be attributed to differences in symptom
status. Overall, futurework that uses a more appropriate con-
trol group (i.e., clinically symptomatic controls without head
trauma history) is needed to better understand the etiology
and differences of WMSAs in former NFL players.
Although WMSAs are nonspecific neuroimaging find-
ings, two etiologies that may underpin the association
Fig. 1. Greater exposure to repetitive head impacts is associated with increased volume of white matter signal abnormalities. Scatter plot shows the relationship
between the cumulative head impact index (x-axis) and volume of white matter signal abnormalities (y-axis, log-scale). This relationship was statistically sig-
nificant after controlling for age, supratentorial volume, and the modified Framingham Stroke Risk Profile score (P 5 .043).
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between exposure to RHIs and later-life WMSAs in former
NFL players are included in the following sections.
4.1. Microvascular pathologies from RHIs and CTE
WMSAs typically accompany aging and CVD and reflect
small-vessel ischemic disease due to microvascular
cerebral hypoperfusion [13–17]. Microvascular cerebral
hypoperfusion and resulting ischemia likely contribute to
the association between RHIs and WMSAs. A single mTBI
can cause acute decreases in cerebral perfusion, and such
changes to perfusion levels may explain findings that link
mTBI with WMSAs on MRI [22,23]. RHIs may lead to
persisting alterations in cerebral perfusion. For example,
chronically impaired cerebral hemodynamic was observed
in 12 professional boxers and was associated with
cumulative rounds of and intensity of sparring [25]. Previous
research also reports reductions in cerebral perfusion in
former NFL players [7,8]. Furthermore, CTE has been well-
documented in former NFL players [2], and microvascular
injury from RHIs has been theorized to contribute to the path-
ogenesis of the perivascular nests of p-tau deposits at the base
of the sulci in CTE [27–29]. This is based on
neuropathological evidence linking microvascular and tau
pathology in boxers [29] and a case study correlating blood-
brain barrier leakage (which can underlie small-vessel disease
[49]) with CTE pathology [30]. These RHI-related microvas-
cular changes can be captured on MRI as WMSAs, and MRI
WMSAs have been found at the gray and white matter junc-
tion in active collegiate ice hockey players [26]. Importantly,
the presence of CTE in the current sample is unknown. It is
plausible that underlying CTE neuropathology is present in
this sample of former NFL players because of their symptom-
atic status and high level of exposure to RHIs. Indeed, a recent
autopsy case series found neuropathological evidence of CTE
in 110/111 former NFL players who donated their brain for
research [4]. Clinicopathological correlation studies will in-
crease our understanding on the relationships among RHIs,
WMSAs, CVD, and CTE.
4.2. Nonmicrovascular pathologies from RHIs and CTE
Gliosis and neuroinflammation are long-term correlates of
RHIs [2,9,31] and CTE [2,5] that can lead to WMSAs [35–
37]. Diffuse axonal and white matter injuries are a
characteristic consequence of concussion and subconcussive
head trauma [50] that can persist into later life in individuals
exposed to RHIs [33,34]. White matter injury and
degeneration is also found in most cases of CTE [2,5].
Based on diffusion tensor imaging (DTI) studies in acute
mTBI [51], WMSAs may reflect diffuse axonal injury associ-
ated with RHIs. Evaluation of WMSAs is clinically routine
and thus the focus of this study. However, DTI has increased
Table 2
Clinical test performance in the former NFL players
Measures
Mean (standard
deviation)
Verbal episodic memory (T-scores)
NAB List Learning Short Delay 46.06 (12.75)
NAB List Learning Long Delay 42.77 (13.94)
NAB Story Learning Immediate Recall 39.73 (7.99)
NAB Story Learning Delayed Recall 42.63 (7.53)
Visual episodic memory (T-scores)
ROCFT Immediate Copy, Presence, and Accuracy 48.96 (9.72)
ROCFT Delayed Presence and Accuracy 49.57 (10.68)
Psychomotor speed and executive function (T-scores)
Trail Making Test Part A 49.69 (11.13)
Trail Making Test Part B 44.89 (15.69)
WAIS-R Digit-Symbol Test (scaled score) 10.25 (2.02)
DKEFS Color-Word Interference Test (scaled score) 10.89 (2.81)
Controlled Oral Word Association Test 49.93 (11.34)
Behavior and mood (raw scores)
Beck Depression Inventory-II 16.13 (11.44)
Center for Epidemiologic Studies Depression Scale 22.14 (13.22)
Hamilton Depression Rating Scale 9.54 (7.93)
Beck Hopelessness Scale 4.75 (5.66)
Barratt Impulsivity Scale 65.07 (14.77)
Apathy Evaluation Scale 35.42 (9.70)
Brown-Goodwin Lifetime History of Aggression 18.75 (5.05)
BRIEF-A Behavioral Regulation Index (T-score) 63.04 (12.79)
Abbreviations: BRIEF-A, Behavior Rating Inventory of Executive
Function–Adult (self-report form); DKEFS, Delis-Kaplan Executive
Function System; NAB, Neuropsychological Assessment Battery; NFL,
National Football League; ROCFT, Rey-Osterrieth complex figure test; SD,
standard deviation; WAIS-R, Wechsler Adult Intelligence Scale–Revised.
NOTE. All cognitive test results are presented as demographically cor-
rected T-scores (mean 5 50, SD 5 10) except where noted. The tests pre-
sented include those that make up that four PCA-generated factor
composite scores examined in this study, i.e., behavior/mood, psychomotor
speed and executive function, and verbal and visual episodic memory. Sam-
ple size varies (N5 81 to N5 84) across tests due to missing data and two
individuals are excluded from clinical analyses due to objective test evi-
dence of intentional symptom exaggeration.
Table 3
Linear regression models showing relationships between white matter
signal abnormalities, repetitive head impact exposure, and psychomotor/
speed executive function in the former NFL players (N 5 86)
Model variables b (SE) 95% CI P-value
Log-white matter signal abnormalities
Age 0.01 (0.004) 0.002, 0.02 .021
Supratentorial volume 0.0004 (0.0003) 20.0002, 0.001 .17
Modified FSRP 0.01 (0.01) 20.01, 0.03 .30
CHII 0.01 (0.004) 0.0002, 0.02 .043
Psychomotor speed/executive function
Age 0.02 (0.01) 20.01, 0.05 .12
Supratentorial volume 0.003 (0.001) 0.001, 0.005 .001
Modified FSRP 20.06 (0.03) 20.12, 0.01 .08
White matter signal
abnormalities
20.11 (0.04) 20.19, 20.02 .015
Abbreviations: CHII, cumulative head impact index; CI, confidence inter-
val; FSRP, Framingham Stroke Risk Profile.
NOTE. The FSRP is a modified version and did not include left ventric-
ular hypertrophy. Age, supratentorial volume, and the modified FSRP were
entered in block 1 of the regression model, and the CHII and white matter
signal abnormalities were in block 2 (of separate models). Supratentorial
volume, CHII, and white matter signal abnormalities were divided by
1000 to facilitate model fit. Bolded text indicates statistical significance.
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sensitivity to microstructural alterations (compared to
WMSAs) and would be optimal for the early detection of
white matter injury associated with exposure to RHIs and/or
CTE. Previous work in former NFL players supports the util-
ity of DTI in this setting [7]. Multimodal neuroimaging
studies that correlateWMSAswith RHI- and CTE-related pa-
thologies (e.g., p-tau from positron emission tomography im-
aging and axonal injury from DTI) will help to clarify the
etiology of WMSAs in former NFL players.
4.3. WMSAs and clinical function
The pathologies of WMSAs contribute to the clinical pre-
sentation of AD [14,39,52–54], and similar effects may be
present in CTE. CTE is associated with cognitive, behavioral,
and mood deficits, with heterogeneity in severity and course
potentially due to modifiers like WMSAs [3,44]. In this
study, greater volume of WMSAs predicted worse
psychomotor speed and executive function—domains
impacted by microvascular disease and CTE. There was no
relationship between WMSAs and behavioral/mood and
episodic memory, perhaps, because brain regions that
modulate these clinical functions were not affected by
WMSAs. The clinical effects of the pathologies of WMSAs
maybedependent on their specific anatomical location [38,53].
4.4. Limitations
There are several limitations associated with this study. To
calculate the CHII in this sample of former NFL players, head
impact frequencies from published helmet accelerometer
studies in college football players were used to estimate pro-
fessional exposure, and therefore, the CHII actually underes-
timated the extent of RHI exposure in this sample. Accurate
retrospective quantification of recurrent concussion and sub-
concussive head injuries in formerNFL players is challenging
due to the remote and ambiguous nature of these events.
Development and validation of RHI metrics should continue
to be a target of future research. The etiologies ofWMSAs are
multifaceted, but often related to CVD. The mFSRP is not an
exhaustive index of CVD and several of the components that
make up the FSRP rely on self-report rather than direct assess-
ment (e.g., fasting glucose levels). Overall, CVD is a preva-
lent comorbidity in former NFL players [19,20], and it
cannot be ruled out as a potential contributor to WMSAs in
this sample of former NFL players.
It is unlikely that there is a competing neurodegenerative
disease (e.g., AD) in the present sample due to the young age
of the former NFL players (mean age 5 55) [4]. The pres-
ence and severity of CTE in the former NFL players are un-
known, and on average, the neuropsychological status of the
sample was largely within normal limits. Only a subset of in-
dividuals who may be driving the current findings may have
meaningful pathology. This is exemplified by a previous
study showing significant variability in plasma total tau con-
centrations in the DETECT sample [43]. There is variability
in both RHI exposure and WMSA burden in this sample
(Fig. 1). For example, the one participant with the highest
CHII score also had significant WMSA burden (relative to
the other former NFL players) and clinical impairment
(i.e., 1 SD below the mean on psychomotor speed and exec-
utive function). It is participants like this that possibly repre-
sent the target population, that is, those with likely CTE, and
are driving the current findings. The present study needs to
be repeated once CTE can be diagnosed during life. Indeed,
not all individuals who play football or are exposed to RHIs
develop long-term neurological consequences, and other
risk factors, for example, apolipoprotein E (APOE), may
interact with RHIs to increase one’s susceptibility to the
long-term effects of RHIs on the brain.
We did not examine the spatial distribution of WMSAs.
FreeSurfer provides an automated approach to quantify
total volume of T1 white matter hypointensities. Although
this approach is frequently used in clinical research inves-
tigations on WMSAs, FreeSurfer’s labeling of WMSAs
tends to be more restricted to certain regions of the brain
tissue (e.g., periventricular) [55–57]. The spatial
distribution of WMSAs may be distinct across different
neurodegenerative diseases [52] and can also provide
insight into the cognitive domains they may influence.
FLAIR also has increased sensitivity to WMSAs and is
routine in the clinical evaluation of WMSAs because they
appear as bright spots. Future work that uses FLAIR MRI
is needed to clarify the spatial patterns of WMSAs in
former professional football players compared with older
adults, as well as other neurodegenerative disease compar-
ison groups (e.g., AD).
Finally, there was one African American in the control
group, whereas 41.9% of the former NFL players were Af-
rican American. A similar proportion (39%) of African
Americans was found in 3439 former NFL players [19].
Because only one control was African American, race
was not included as covariate in the between-group ana-
lyses as it would not allow for accurate estimation of the
differential effects of race on WMSAs across the two study
groups. In the former NFL players, the relationship be-
tween the CHII and WMSAs remained statistically signif-
icant after race was added as a covariate; the association
between WMSAs and psychomotor speed and executive
function was diminished to a statistical trend. Compared
to Caucasians, African Americans had greater volume of
WMSAs and worse psychomotor speed and executive func-
tion. This is consistent with research that shows African
Americans can exhibit more severe WMSAs [58], which
may contribute to the association between African Amer-
ican race and poor neurological outcomes, including
increased risk for AD dementia [59]. This relationship,
however, appears to be dependent on genetic, clinical,
and environmental factors [59]. To better understand race
and WMSAs in former NFL players, the present study
needs to be repeated with a larger and demographically
matched control group.
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5. Conclusions
WMSAs in former professional American football
players may reflect long-term microvascular and nonmicro-
vascular pathologies from RHIs that are associated with
cognition. Future studies that longitudinally examine
WMSAs and clinical function in individuals at high risk
for CTE and investigate the associations among WMSAs
and RHI- and CTE-specific pathology will increase our un-
derstanding of the clinical implications of WMSAs in CTE.
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RESEARCH IN CONTEXT
1. Systematic review: We reviewed the literature using
PubMed and references of research articles. Neuroi-
maging has been used to study the long-term neuro-
logical effects of repetitive head impacts (RHIs) and
identify methods to detect chronic traumatic enceph-
alopathy (CTE) during life. No study, however, has
examined the presence and clinical correlates of white
matter signal abnormalities (WMSAs) in former Na-
tional Football League (NFL) players. This is despite
WMSAs having been examined in the setting of acute
mild traumatic brain injury and Alzheimer’s disease;
these studies are appropriately cited.
2. Interpretation: In former NFL players, WMSAs
may reflect long-term microvascular and non-
microvascular pathologies from RHIs that are associ-
ated with cognition.
3. Future directions: Multimodal neuroimaging studies
that examine WMSAs and RHI- and CTE-related pa-
thologies will likely clarify the etiology ofWMSAs in
NFL players. Once CTE can be diagnosed in life,
longitudinal studies should examine whether WMSAs
predict risk for and clinical progression of CTE.
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